Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: j_fir2 who wrote (2879)	5/22/1999 11:10:00 AM
From: George Dawson	Read Replies (1) of 10280

I don't think the issue is necessarily if a new antidepressant will come along that is superior to Prozac. I can assure you that antidepressant trial results can be controversial and depending on the methodology used - some show negligible benefits over placebo. Clinical trials for the FDA use a fairly standard protocol. I mention this only because it would probably take a vastly superior antidepressant to demonstrate clear benefits over the others. One area that doesn't seem to be considered is the competition between a different isomer and fluoxetine (generic Prozac). If Prozac is widely prescribed and effective now and most people are not getting side effects that would cause them to stop taking it - that would seem to be formidable competition to the new isomer. George D.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next